Professor Melvin Lobo

Professor Melvin Lobo is a senior Consultant Cardiovascular Physician based in the Barts Heart Centre and the William Harvey Research Institute. He has a specialist interest in blood pressure disorders of all types, autonomic control of the circulation and also resistant hypertension and device-based therapies thereof. He is an accredited Clinical Hypertension Specialist of the European Society of Hypertension (ESH) and British Hypertension Society.

Professor Lobo is Director of the Bart's Blood Pressure Clinic which is a Hypertension Centre of Excellence and receives referrals of patients with complex circulatory disorders on a national/international basis and has contributed to several landmark studies in hypertension, particularly in the field of novel device therapy of hypertension. His research work has been featured on television and in the national press on numerous occasions (see website for details: http://www.hypertensionspecialist.co.uk/).

In addition to hypertension, he is also an acknowledged expert in the management of low blood pressure (hypotension) and BP variability disorders and PoTS (postural tachycardia syndrome) and sees patients on a national basis with these issues in the Barts BP Clinic and on an international basis in his private practice. He has the largest cohort of medication intolerant patients nationally and has evolved, published and lectured on specialised strategies with liquid and patch formulations of antihypertensives to get around intolerances to tablets.

He is recognised globally as a key opinion leader in his field and this is reflected in numerous roles in multicentre clinical trials, invited lectures at major conferences and also as an editor/reviewer of numerous journals including JACC and Lancet. More recently he has authored national and co-authored international guidelines for device therapy of hypertension which were published in the prestigious European Heart Journal.

He organises and co-chairs the UK Annual Symposia on Device Therapy of Hypertension with a distinguished panel of international authorities in hypertension medicine. He is a specialist adviser to NICE and the European Society of Hypertension on interventional therapies in hypertension and a member of the Council on Hypertension of the European Society of Cardiology.